Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Digital Transformation Opportunities (DTOCW) Competitors

DTOCW vs. ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, and VSEE

Should you be buying Digital Transformation Opportunities stock or one of its competitors? The main competitors of Digital Transformation Opportunities include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), and VSee Health (VSEE). These companies are all part of the "healthcare" industry.

Digital Transformation Opportunities vs. Its Competitors

Aclarion (NASDAQ:ACONW) and Digital Transformation Opportunities (NASDAQ:DTOCW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled Digital Transformation Opportunities'average media sentiment score.

Company Overall Sentiment
Aclarion Neutral
Digital Transformation Opportunities Neutral

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Digital Transformation Opportunities N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$62.95KN/AN/AN/AN/A
Digital Transformation OpportunitiesN/AN/AN/AN/AN/A

Summary

Aclarion beats Digital Transformation Opportunities on 1 of the 1 factors compared between the two stocks.

Get Digital Transformation Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for DTOCW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DTOCW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DTOCW vs. The Competition

MetricDigital Transformation OpportunitiesServices – Health IndustryBusiness SectorNASDAQ Exchange
Market CapN/A$9.91M$24.36B$9.71B
Dividend YieldN/AN/A2.81%4.09%
P/E RatioN/AN/A28.3625.97
Price / SalesN/AN/A38.91120.77
Price / CashN/AN/A25.8458.38
Price / BookN/AN/A5.916.37
Net IncomeN/A-$40K$197.30M$265.56M

Digital Transformation Opportunities Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DTOCW
Digital Transformation Opportunities
N/A$1.19
-8.5%
N/AN/A$0.00N/A0.001,520
ACONW
Aclarion
N/A$0.03
-0.3%
N/A+62.2%$0.00$54.60K0.007Positive News
AONC
American Oncology Network
N/A$11.00
+6.9%
N/A+246.5%$0.00$1.34B0.001,520
DHACW
Digital Health Acquisition
N/A$0.05
-9.0%
N/AN/A$0.00N/A0.00N/AGap Down
FMS
Fresenius Medical Care AG & Co. KGaA
2.8104 of 5 stars
$24.09
+1.1%
$27.80
+15.4%
+32.8%$0.00$20.63B19.751,384News Coverage
Short Interest ↑
LFMDP
LifeMD
N/A$23.88
+0.5%
N/A+8.9%$0.00$245.56M0.00230
OTRKP
Ontrak
N/A$0.02
+4.0%
N/A-90.1%$0.00$10.84M0.00250High Trading Volume
PIIIW
P3 Health Partners
N/A$0.01
flat
N/A-55.9%$0.00$1.49B0.00500Gap Down
TALKW
Talkspace
N/A$0.07
-0.1%
N/A+78.3%$0.00$202.61M0.00500
TOIIW
Oncology Institute
N/A$0.18
+71.2%
N/A+553.3%$0.00$403.15M0.00660Gap Up
High Trading Volume
VSEE
VSee Health
1.5395 of 5 stars
$1.32
-3.6%
$5.00
+278.8%
-50.8%$0.00N/A0.00N/AGap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:DTOCW) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners